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Abstract This study evaluates the neuropharmacological ef-
fects of the aqueous extract of the Mexican plant Calea
zacatechichi Schltdl., which is commonly used in folk medi-
cine to treat cough, asthma, and gastrointestinal disorders.
Moreover, it has been used for centuries in traditional rituals
based on divination and is thought to possess hallucinogenic
activity. To test the neuropharmacological effects of the aque-
ous extract of C. zacatechichi we used mouse models of con-
vulsions, an elevated plus-maze test and measured locomotor
activity. We also evaluated the effect of the extract on
antidepressant-like behavior in forced swim test, as well as
on muscular strength in a grip test. Moreover the
antinociceptive action of the extract was evaluated in the
hot-plate and writhing tests. The chemical composition of
the extract was evaluated using LC-MS techniques. The aque-
ous extract of C. zacatechichi did not affect any of the param-
eters measured in seizure models. It had also no influence on
anxiety, exploratory behavior and muscular strength in the
applied doses. On the other hand, the extract exhibited
antinociceptive effect in the mouse model of abdominal pain.
Chemical characterization of the extract showed the presence
of chlorogenic acid, acacetin, and germacranolides. Based on
this report we suggest that aqueous extract of C. zacatechichi
has insignificant neuropharmacological effects in vivo and
reduces abdominal pain perception. Our results, together with
previous studies showing beneficial effects of the extracts ob-
tained from C. zacatechichi suggest that these preparations
may be used to treat medical conditions.
Keywords Anticonvulsant activity . Seizure threshold .
Abdominal pain .Mice
Introduction
Calea zacatechichi Schltdl. (Asteraceae alt. Compositae) is a
Latin-American plant, also known as Dream Herb or Bitter
Grass, which grows predominantly in south-eastern Mexico.
Native Indian tribes have used it for centuries as a remedy for
cough and asthma, as well as gastrointestinal (GI) tract disor-
ders, such as stomach-ache and diarrhea (Leonti et al. 2003).
To date, several scientific reports have shown beneficial ef-
fects of C. zacatechichi extracts. For example, Wu et al.
(2011) characterized anti-microbial and anti-leishmanial activ-
ity of compounds isolated from C. zacatechichi. Venegas-
Flores et al. (2002) reported anti-inflammatory properties of
C. zacatechichi aqueous extract. Furthermore, Bork et al.
(1997) demonstrated that C. zacatechichi leaves extract nega-
tively interfered with activation of Nf-κB transcriptional fac-
tor. Most recently, Sałaga et al. (2015) showed that dichloro-
methane extract of C. zacatechichi has anti-diarrheal and anti-
nociceptive effects in the GI tract.
Apart from its medicinal properties, C. zacatechichi is also
known to have some central nervous system (CNS)-related
effects. Several Indian tribes, such as Chontal Indians used C.
zacatechichi for rituals aimed at dream-based divination (Wu et
al. 2011). In line, it has been reported that C. zacatechichi has
some hallucinogenic properties and may affect sleep. Its
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organic extracts induce somnolence-like behaviors accompa-
nied by the changes in EEG and light sleep in cats
(Mayagoitia et al. 1986). Large doses elicit salivation, ataxia
and retching (Mayagoitia et al. 1986). A double-blind human
study by Mayagoitia et al. demonstrated that in healthy volun-
teers, low doses of C. zacatechichi extracts increased reaction
time and time-lapse estimation (Mayagoitia et al. 1986).
Moreover, it has been shown that the effects of the plant upon
cingulum discharge frequency were significantly different from
other hallucinogenic drugs, such as ketamine, quipazine and
phencyclidine (Mayagoitia et al. 1986). In the light of the cur-
rently available scientific literature it is difficult to estimate
whether therapeutic effects of C. zacatechichi extracts would
be affected by CNS-related effects and, if any, which types of
extracts are particularly abundant in hallucinogenic com-
pounds. To shed light on the neuropsychopharmacological pro-
file of the plant and its constituents, we investigated the effect of
C. zacatechichi aqueous extract on seizure threshold, muscular
strength, mood-related symptoms and locomotor activity in
mice. Furthermore we assessed the antinociceptive properties
of the extract in models of centrally- and peripherally-mediated
antinociception. We also characterized the chemical composi-
tion of the extract by mass spectrometry to find novel biologi-
cally active compounds responsible for its potential effects.
Materials and methods
Plant material
Dried shredded herb of Calea zacatechichi (leaves, stems and
flowers) was purchased from the company Maya
Ethnobotanicals (Haarlem, Netherlands). The material originat-
ed from Mexico according to the provider declaration. The au-
thenticity of the purchased material was confirmed through the
macroscopic and microscopic assessment which was carried out
in comparison to the authenticatedC. zacatechichimaterial from
Daniel Siebert, provided by The University of Mississippi
School of Pharmacy, Mississippi, MS, USA. The plant name
has been checked with http://www.theplantlist.org on 30–10-
2013.
Extract preparation
Powdered C. zacatechichi herb (150 g) was extracted 4 times
with 2 l of boiling water. The aqueous solution was filtered
and lyophilized.C. zacatechichi aqueous extract was prepared
in the National Medicines Institute, Warsaw, Poland.
Animals
Experimentally naïve, age matched male albino Swiss mice
(Laboratory Animals Breeding, Słaboszów, Poland) weighing
22–30 g were used in all experiments. The animals were
housed in Makrolon cages under strictly controlled laboratory
conditions (22–23 °C, relative humidity, 45–55 %, 12 h light/
dark cycle, lights on at 6:00 a.m.). Chow pellets (Agropol S.J.,
Motycz, Poland) and tap water were available ad libitum.
After at least 7 days of acclimatization, experiments were
performed between 8:00 and 16:00 h to minimize circadian
influences. Each animal was used only once. The experimen-
tal protocol was in accordance to the European Communities
Council Directive of 22 September 2010 (2010/63/EU) and
Polish legislation acts concerning animal experimentations
and was approved by the Local Ethics Committee at the
Medical University of Lublin (license number 45/2013).
Drug administration
All drugs and reagents, unless stated otherwise, were purchased
from Sigma-Aldrich (Poznań, Poland). The C. zacatechichi
aqueous extract (powder) was diluted in saline to desired con-
centrations and administered orally (p.o.) by gastric gavage in a
volume of 10 ml/kg 60 min before the respective test. In time
course experiments the C. zacatechichi extract was adminis-
tered p.o. 15, 30, 60, 120 and 240 min before the test.
Control animals received saline alone (p.o.). The vehicles in
the used concentrations had no effects on the observed param-
eters. The dilutions of the C. zacatechichi extract used in this
study were chosen based on preliminary experiments, in refer-
ence to doses used in humans.
Maximal electroshock seizure threshold (MEST) test
in mice
The electroshock seizures were induced by sine-wave alter-
nating current (maximal output voltage 500 V, 50 Hz for 0.2 s)
applied via transcorneal electrodes. The current was delivered
by a rodent shocker (type 221; Hugo Sachs Elektronik,
Freiburg, Germany). An ocular anesthetic (1 % solution of
tetracaine hydrochloride) was applied into each eye 1 min
before stimulation to minimize the pain. Transcorneal elec-
trodes were soaked in 0.9 % saline to maximize the conduc-
tance. During stimulation mice were manually immobilized
and immediately after the stimulation they were placed in a
Plexiglas arena (37 cm × 21 cm × 14 cm) for behavioral
observation. The presence or absence of seizure activity was
recorded. Tonic hindlimb extension was taken as an endpoint.
The thresholds for maximal electroconvulsions were
assessed by the ‘up-and-down’ method described by Kimball
et al. (1957). In this method, current intensity was lowered or
raised by 0.06-log intervals depending on whether the previous-
ly stimulated animal did or did not exert seizure activity, respec-
tively. Each mouse was stimulated only once at any given cur-
rent intensity. Experimental groups comprised 18–20 animals.
Obtained data was used to determine the threshold current
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causing an endpoint in 50 % of mice (CC50 with confidence
limits for 95 % probability). For further methodological detail
see: Giardina and Gasior (2009).
The 6 Hz psychomotor seizure threshold test in mice
The psychomotor seizure thresholds were examined using
square-wave alternating current stimuli (0.2-ms duration
pulses at 6 Hz for 3 s) delivered via saline-soaked corneal
electrodes by a Grass S48 stimulator coupled with a constant
current unit CCU1 (both from Grass Technologies, West
Warwick, RI, USA). Ocular anesthesia and observation arena
were made as described in above section. The seizures in-
duced by 6 Hz stimulation were characterized by immobility
or stun posture, which was frequently followed by rearing,
forelimb clonus, twitching of the vibrissae and elevated or
Straub tail (Barton et al. 2001; Barton et al. 2003). Renewal
of normal exploratory behavior or the absence of the features
listed above within 10 s after stimulation were considered as
the lack of seizures. The ‘up-and-down’ method described by
Kimball et al. (1957) was used in order to choose the current
intensity. Data obtained in groups of 19–20 animals were used
to determine the threshold current causing 6 Hz-induced sei-
zures in 50 % of mice (CC50 with confidence limits for 95 %
probability).
The intravenous pentylenetetrazole (PTZ) seizure
threshold test in mice
Briefly, mice were placed in a cylindrical plastic restrainer
(12-cm long, 3-cm inner diameter) and a 27-gauge needle
(Sterican®, B. Braun Melsungen, Melsungen, Germany) was
inserted into the lateral tail vein. The needle was attached by
polyethylene tubing (PE20RW, Plastics One Inc., Roanoke,
VA, USA) to a plastic syringe, which was mounted in a sy-
ringe pump (model Physio 22, Hugo Sachs Elektronik–
Harvard Apparatus GmbH, March-Hugstetten, Germany).
The correct needle placement in the tail vein was verified by
the appearance of blood in the tubing. The 1 % aqueous solu-
tion of PTZ, was administered into the lateral tail vein of
unrestrained animals at a constant rate of 0.2 ml/min.
Endpoints recorded to determine seizure thresholds: (1) the
initial myoclonic twitch, (2) the onset generalized clonus with
loss of righting reflex and (3) the onset of tonic forelimb ex-
tension. The time elapsed from the start of PTZ infusion to the
onset of all three seizure stages was measured. The thresholds
were calculated separately for each endpoint according to the
formula: threshold dose of PTZ (mg/kg) = (infusion duration
(s) × infusion rate (ml/s) × PTZ concentration (mg/
ml) × 1000)/body weight (kg). Seizure thresholds were
expressed as the amount of PTZ (mg/kg) ± SEM needed to
produce the first sign of each endpoint in groups of 10–14
mice.
Forced swim test
Forced swim test was performed according to the modified
method of Porsolt et al. (1977). Mice (10–12/group) were
individually placed into the glass cylinders (height 25 cm,
diameter 10 cm) containing 10 cm of water maintained at
23–25 °C and left in it for 6 min. The total duration of immo-
bility was recorded during the last 4 min of the 6-min testing
period. The mice were considered immobile when they
remained floating motionless in the water, making only the
slow movements necessary to keep their heads above the
water.
Elevated plus-maze test
To identify anxiolytic properties of the studied extract we used
elevated plus-maze test in mice, as described earlier by Lister
(1987). The plus-maze apparatus was made of black polyvinyl
chloride and consisted of two open (30 × 5 cm) and two
enclosed (30 × 5 × 15 cm) arms. The arms extended from a
central platform of 5 × 5 cm. The apparatus was mounted
38 cm above the floor level and was illuminated by red light.
Animals (12 mice per group) were placed in the center of the
apparatus (facing an enclosed arm), allowed to freely explore
the maze and observed for 5 min. The following parameters
were recorded: total number of arm entries, number of entries
into the open arms and the time spent in these arms. An entry
was defined as crossing the boundaries of the arms with all
four paws. The percentage of entries and time spent in the
open arms were calculated.
The grip-strength test in mice
The effect of the studied extract on skeletal muscle strength
in mice was measured in the grip-strength test, as described
before (Nieoczym et al. 2010). The grip-strength apparatus
(BioSeb, Chaville, France) consisted of a steel wire grid
(8 × 8 cm) connected to an isometric force transducer.
Animals (12 mice/group) were lifted by the tail so that they
could grasp the grid with their forepaws. Then animals
were pulled backward gently by the tail until they released
the grid. The maximal grip strength value (in newtons, N)
of the animal was recorded. The procedure was repeated
three times and the mean force exerted by each mouse was
recorded. The mean force was normalized to body weight
and expressed in N/g.
Locomotor activity
To monitor the spontaneous locomotor activity of mice, an IR
Actimeter system (Panlab/Harvard Apparatus, Barcelona,
Spain) was used. This consisted of a square arena surrounded
by a 25 × 25 cm frame, containing a total of 16 × 16 infrared
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beams located on the sides and spaced at 1.5 cm intervals.
Mice (11 per group) pretreated with C. zacatechichi aqueous
extract or vehicle were placed individually in the actimeter
and allowed to freely explore the arena for 6 min. The number
of crosses of the infrared beams was counted by the device
within last 4 min of the test, what corresponds to the time
interval analyzed in the forced swim test.
Behavioral pain responses
Hot-plate test
The hot-plate test was performed according to the method
described earlier (Eddy and Leimbach 1953; Sobczak et al.
2014). A transparent plastic cylinder (14 cm diameter, 20 cm
height) was used to confine the mouse on the heated
(55 ± 0.5 °C) metal plate. Animals (12 mice/group) were
administered with vehicle or C. zacatechichi aqueous extract
(200 mg/kg, p.o.) and gently placed on the hot-plate. The
latencies to paw licking, rearing and jumping were measured.
A cut-off time of 240 s was used to avoid thermal skin injury.
The dose of 200 mg/kg used in behavioral pain tests was
selected, as the lowest from the doses tested in neuropharma-
cological tests which did not cause any CNS-related adverse
events.
Writhing test
The writhing test was performed as described earlier (Laird et
al. 2001; Sałaga et al. 2014). After administration of vehicle or
C. zacatechichi aqueous extract (200 mg/kg, p.o.), mice (12
mice/group) were injected intraperitoneally (i.p.) with 0.75 %
(v/v in saline) acetic acid solution (10 ml/kg). After 5 min of
recovery, mice were placed in individual observational cages
and the total number of writhes was counted during three
periods of 5 min each. The writhing response, regarded as a
nociceptive behavior, was characterized by elongation of the
body and the development of tension in the abdominal mus-
cles and hind paws.
LC-MS method
A tandem mass spectrometer MicrOTOF-Q II from Bruker
Daltonics (Bremen, Germany) coupled with an LC-UV
Ultimate 3000 system (Dionex, a part of Thermo Fisher
Scientific) was used to obtain the electrospray ionization
time-of-flight mass spectra (LC-ESI-MS/MS-TOF). The fol-
lowing settings were used: electrospray ionization (ESI) in the
positive ion mode, dry gas (nitrogen) flow rate 8.0 l/min, the
dry heater 180 °C, the capillary voltage 4500 Vand end plate
offset −500 V. MS data were recorded in the full scan mode
(from 50 to 3000 m/z). Data processing was carried out with
Compass 1.3 (Bruker Daltonics).
Chromatographic analysis was performed on a C18 analyt-
ical column (Hypersil GOLD, 150 mm × 2.1 mm; 3 μm par-
ticle size; Thermo Fisher Scientific,Waltham,MA, USA)with
a guard column (Hypersil GOLD, 10 mm × 2.1 mm; 3 μm
particle size; Thermo Fisher Scientific, Walthman, MA,
USA). The linear gradient elution was performed using
0.1 % formic acid in solvent A (water/acetonitrile, 9:1, v:v)
and 0.1 % formic acid in solvent B (methanol/acetonitrile, 9:1,
v:v). An applied linear gradient was as follows: initially 10 %
B from 0 to 2 min, then linear gradient to 90 % B at 7 min,
constant 90 % B to 10 min, finally return to 10 % B and
equilibration for 2 min. The flow rate was 0.15 ml/min and
the injection volume was 2 μl. The analysis was carried out at
25 °C.
To identify individual compounds we analyzed the high
resolution mass spectra. TOF analyzer enables a very accurate
mass detection and the assignment to the most probable mo-
lecular formula. Suggested molecular formulas were accepted
when the mass error was below 5 ppm. Additionally we en-
hanced the identification by the analysis of the isotopic pattern
of the compounds. When possible, obtained MS/MS spectra
were additionally compared with spectra of identified com-
pounds in the METLIN: Metabolite and Tandem MS
Database (http://metlin.scripps.edu).
Statistical analysis
Data obtained from the MEST test and the 6 Hz seizure
threshold test were analyzed according to Kimball et al.
(1957) and are presented as CC50 values with 95% confidence
limits. Differences in CC50 values were analyzed by using
one-way analysis of variance (ANOVA) followed by
Dunnett’s post hoc test. All other results are expressed as
means ± SEM and were analyzed by one-way ANOVA
followed by Dunnett’s post hoc test or Student’s t test (loco-
motor activity). Statistical significance was noted when p
values were equal to or less than 0.05. All statistical calcula-
tions were performed with GraphPad Prism version 5.03 for
Windows (GraphPad Software, San Diego, CA, USA).
Results
Aqueous extract of C. zacatechichi does not affect
the threshold in the MEST test in mice
To establish whether aqueous extract of C. zacatechichi has
the ability to prevent seizure spread through neural tissue, we
used MEST test. Aqueous extract of C. zacatechichi adminis-
tered at doses ranging from 200 to 800 mg/kg (p.o.) did not
affect the MEST (Fig. 1a).
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Aqueous extract of C. zacatechichi does not influence
the 6 Hz psychomotor seizure threshold in mice
To evaluate the potential influence of aqueous extract of C.
zacatechichi on partial psychomotor seizures, we used 6 Hz
psychomotor seizure threshold test. As shown in Fig. 1b the
aqueous extract ofC. zacatechichi administered at doses rang-
ing from 200 to 800 mg/kg (p.o.) did not affect the 6 Hz
seizure threshold.
Aqueous extract of C. zacatechichi does not affect PTZ
seizure threshold in mice
We also investigated the influence of the aqueous extract ofC.
zacatechichi on PTZ-induced seizure threshold. The aqueous
extract of C. zacatechichi administered p.o. at the doses rang-
ing from 200 to 800 mg/kg did not alter any of the measured
parameters, including myoclonic twitch (Fig. 2a), onset gen-
eralized clonus (Fig. 2b), and tonic forelimb extension (Fig.
2c). Moreover, we investigated the time course of the changes
in measured parameters after a single administration of the
extract (200 mg/kg, p.o., Fig. 3). Only the tonic forelimb ex-
tension was significantly affected by the extract with the
maximum effect observed after 60 min post administration
(Fig. 3c).
Aqueous extract of C. zacatechichi produces
depressive-like effects in the forced swim test
In order to investigate the antidepressant-like effect of the
aqueous extract of C. zacatechichi, we performed a forced
swim test in mice. As shown in Fig. 4, the p.o. administration
of the aqueous extract of C. zacatechichi at doses of 400 and
800, but not 200 mg/kg significantly prolonged the immobil-
ity time of mice.
Fig. 1 Effect of the aqueous extract of C. zacatechichi (200–800 mg/kg,
p.o.) on maximal electroshock seizure threshold and 6 Hz psychomotor
seizure threshold in mice. Figure shows data for CC50 of the MEST (a)
and 6 Hz seizure threshold (b). Data represent mean + SEM of n = 18–20
mice for each experimental group
Fig. 2 Effect of the aqueous extract of C. zacatechichi (200–800 mg/kg,
p.o.) on the pentylenetetrazole seizure threshold in mice. Figure shows
data for myoclonic twitch (a), generalized clonus (b) and forelimb tonus
(c). Data represent mean + SEM of n = 10–13 mice for each experimental
group
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Aqueous extract of C. zacatechichi affects neither
exploratory behavior, nor anxiety levels in mice
The influence of the p.o. administration of the aqueous extract
ofC. zacatechichi on mouse locomotor activity was measured
over a 6 min period. The extract administered at a dose of
800 mg/kg did not modify the horizontal activity (Fig. 5).
To identify potential differences in exploratory behavior
and changes in anxiogenic or anxiolytic activity after
administration of aqueous extract of C. zacatechichi vs. con-
trol mice, an elevated plus-maze test was used. No significant
differences were found for measures of anxiety, such as the
percentage of entries (Fig. 6a) and time spent (Fig. 6b) in the
open sector after p.o. administration of the extract at the dose
of 400 and 800 mg/kg.
Aqueous extract of C. zacatechichi does not affect muscle
strength in mice
In order to determine the effect of aqueous extract of C.
zacatechichi on neuromotor functions of the muscles, we used
grip-strength test. The extract administered at the doses rang-
ing from 200 to 800 mg/kg, (p.o.) did not affect the grip
strength in mice (Fig. 7a).
We also investigated the time course of the changes in grip
strength after a single administration of the extract (200 mg/
kg, p.o.). There was no effect on muscle strength between
control and any of the tested time points (Fig. 7b).
Aqueous extract of C. zacatechichi does not produce
CNS-mediated analgesia in mice
To determine whether administration of aqueous extract of C.
zacatechichi induces CNS-mediated antinociception we used
hot-plate test. The extract administered at the dose of 200 mg/
kg (p.o.) did not affect the latencies to paw licking, rearing and
escape jumping (Fig. 8a).
Aqueous extract of C. zacatechichi reduces visceral pain
responses in mice
In order to assess the antinociceptive activity of aqueous ex-
tract of C. zacatechichi in the periphery we used writhing test.
The p.o. administration of C. zacatechichi aqueous extract at
the dose of 200 mg/kg resulted in a significant reduction of the
number of writhes (Fig. 8b).
Fig. 3 The time course of the changes in pentylenetetrazole seizure
threshold after a single administration of the aqueous extract of C.
zacatechichi (200 mg/kg, p.o.). Figure shows data for myoclonic twitch
(a), generalized clonus (b) and forelimb tonus (c) which is significantly
increased 60 min after administration. Data represent mean + SEM of
n = 10–14 mice for each experimental group. *P < 0.05, as compared to
control
Fig. 4 Effect of the aqueous extract of C. zacatechichi (200–800 mg/kg,
p.o.) on the antidepressant-like behavior in the forced swim test. Figure
shows data for immobility time. Data representmean + SEMof n = 10–12
mice for each experimental group. *P < 0.05 as compared to control
636 Metab Brain Dis (2016) 31:631–641
Chemical composition of aqueous extract of C.
zacatechichi
The LC-MS analysis of aqueous extract of C. zacatechichi,
together with a high mass and high isotopic abundance match
allowed us to obtain the most probable chemical formulas for
all detected compounds. As shown in Table 1, the analysis
revealed the presence of 6 constituents, which are quinic acid
derivative (1), flavonol derivatives (2, 3), flavone derivative
(4) and germacranolides (5, 6); the measured accurate ion
mass [M + H]+ of the analyzed compounds are also reported.
Alignment of obtained mass spectra with METLIN library
or published papers (Chouchi and Barth 1994; Liu et al. 2012;
Wu et al. 2011; Zatorski et al. 2015) resulted in the identifica-
tion of following compounds: chlorogenic acid (1), rutin (2)
and rutin without hydroxyl group (3), acacetin (4),
calealactone C (5) and calein A (6).
Discussion
In this study we characterized the neuropharmacological and
antinociceptive effects of the aqueous extract of C. zacatechichi
in vivo. We evidenced that oral administration of the extract
does not affect most of tested neurological and behavioral pa-
rameters, namely MEST, 6 Hz-induced seizure, PTZ-induced
seizures, locomotor activity, plus-maze test measurements, grip
strength and CNS-mediated antinociception. However, we ob-
served significant action in the forced swim test and on one of
the PTZ-induced seizures parameters, as well as significant
antinociceptive effect in the model of abdominal pain.
There are several scientific reports showing beneficial ac-
tions of extracts obtained from C. zacatechichi, including anti-
microbial, anti-inflammatory and anti-diarrheal effects (Bork et
al. 1997; Wu et al. 2011). It has been suggested that the poten-
tial therapeutic use of C. zacatechichi may be hampered
by adverse CNS-related events and there are already some ev-
idences in the literature for its potential psychopharmacological
effects. However, these data are poorly characterized. For ex-
ample, Mayagoitia et al. have shown that C. zacatechichi ex-
tracts increase the superficial stages of sleep and the number of
spontaneous awakenings in humans (Mayagoitia et al. 1986). It
was also reported that volunteers subjected to the C.
zacatechichi extracts experienced more intense dreams during
the sleep (Mayagoitia et al. 1986). Here we provide novel,
relevant data, which extend the existing knowledge and show
the possible negative effects of the compounds occurring in the
aqueous extract of C. zacatechichi.
To begin with, we used three seizure models, which are
broadly applied to test novel anti-convulsant drugs; namely
MEST, 6 Hz-induced seizure and PTZ-induced seizures. The
aqueous extract of C. zacatechichi did not change any of the
measured parameters, except for a slight increase in the dose
of PTZ necessary to induce forelimb tonus 60 min after ad-
ministration of the extract. Of note, this effect was not dose-
dependent and was present only in the time course experi-
ment. These observations may be perceived as a virtue of
the tested extract, as many hazardous, psychoactive and/or
addictive compounds are known to dramatically alter PTZ
convulsion threshold. For instance, (Himmel 2008) has shown
that diazepam (10 mg/kg, p.o.) and morphine (10 mg/kg, i.p.)
Fig. 6 Effect of the aqueous extract of C. zacatechichi (400 and 800 mg/
kg, p.o.) on percentage of entries (a) and time spent (b) in the opened area
of elevated plus-maze. Data represent mean + SEM of n = 12 mice for
each experimental group
Fig. 5 Effect of the aqueous extract of C. zacatechichi (800 mg/kg, p.o.)
on the locomotor activity of mice. Data represent mean + SEM of n = 11
mice for each experimental group
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significantly increased PTZ convulsive threshold, while
isoniazide (120 mg/kg, s.c.) and yohimbine (8 mg/kg, s.c.)
displayed significant and reliable proconvulsive effects. On
the other hand, generally safe compounds, such as caffeine
and acetylsalicylic acid remained ineffective in this test.
Moreover, the aqueous extract of C. zacatechichi did not
alter the CC50 in the MEST test, suggesting the lack of CNS-
related effects. Previously published data show that well-
known psychoactive compounds, such as amphetamine and
its derivatives, cocaine and opioids typically increase seizure
threshold at small doses and produce convulsions at higher
ones (Bankstahl et al. 2012). The measurements of locomotor
activity and several parameters in the elevated plus-maze
showed changes neither in exploratory, nor in anxiety-related
behaviors after administration of the aqueous extract of C.
zacatechichi. This is in line with our previous observations,
showing the lack of changes in exploratory behavior after ad-
ministration of dichloromethane extract of C. zacatechichi in
mice, especially since these two extracts contained similar
groups of compounds (Sałaga et al. 2015).
The aqueous extract of C. zacatechichi was inactive in the
6 Hz psychomotor seizure threshold test. We performed this
test in a standard way, i.e., scoring motor seizure and postictal
depression as total seizure response, without getting and
analyzing the EEG. This might be a limitation of this and other
studies that utilize standard 6 Hz seizure test procedure be-
cause without the EEG it is not possible to distinguish the
convulsive reaction from the postictal immobility, especially
when testing substances that have demonstrated effects on the
CNS functions (Giordano et al. 2015). The duration of
postictal depression may be modulated more than the convul-
sive phase by centrally-active substances.
Of interest, our data showed a significant increase in the
immobility time induced by two doses (400 and 800 mg/kg,
p.o.) of the aqueous extract of C. zacatechichi in a forced
swim test. This observation suggests that the extract may have
a depressant effect in mice tested in this paradigm. However,
the effect was not dose-dependent and thus requires further
investigation, preferably in other paradigms. The LC-MS
analysis of the aqueous extract of C. zacatechichi revealed
presence of three major groups of compounds: chlorogenic
acid, acacetin (and most likely also its derivatives), rutin and
rutin derivative as well as germacranolides.
Chlorogenic acid is a polyphenol and the ester of caffeic acid
and quinic acid that can be found in coffee and black tea, with
potential antioxidant and anti-inflammatory activities (Zatorski
et al. 2015). In this studywe observed that the aqueous extract of
C. zacatechichi, which contains chlorogenic acid, elicited
antinociceptive effect in the mouse model of abdominal pain.
Fig. 8 The antinociceptive effect of aqueous extract of C. zacatechichi
(200 mg/kg, p.o.). Figure shows data for latencies of paw licking, rearing
and escape jumping in the hot-plate test (a) and number of writhes in the
writhing test (b). Data represent mean + SEM of n = 12 mice for each
experimental group. *P < 0.05 as compared to control
Fig. 7 The influence of the aqueous extract of C. zacatechichi on
muscular strength of mice. Figure shows data for the effects on
muscular strength after administration at the doses ranging from 200 to
800 mg/kg, p.o. (a) and the time course of the changes in muscular
strength after a single administration of the extract (200 mg/kg, p.o. (b).
Data represent mean + SEM of n = 12 mice for each experimental group
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This is in line with several studies demonstrating that
chlorogenic acid inhibits abdominal constrictions induced by
acetic acid as well as p-benzoquinone (Chen et al. 2013;
Küpeli et al. 2012; Li et al. 2009). Moreover, pure chlorogenic
acid reduces pain in neuropathic pain models (Bagdas et al.
2013; Bagdas et al. 2014). One of the suggested mechanisms
by which chlorogenic acid alleviates pain is inhibition of acid-
sensing ion channels in peripheral neurons (Qu et al. 2014).
Noteworthy, chlorogenic acid does not induce antinociceptive
effect in the hot-plate test. On the other hand, chlorogenic acid
does not affect the CNS-related functions, such as cognitive
performance and mood-related behaviour suggesting that this
compound is not responsible for the depressant-like effect of
the aqueous extract of C. zacatechichi reported in this study
(Camfield et al. 2013).
Other biologically active compounds found in the extract
were rutin and rutin without one hydroxyl group. Rutin is a
glycoside of quercetin and rutinose occurring in buckwheat
and rhubarb (Kreft et al. 1999). Rutin is a highly potent mol-
ecule due to its strong antioxidant properties. It has been
shown previously that plant extracts containing high concen-
tration of rutin as well as rutin itself induce visceral
antinociception in mice (Lapa et al. 2009; Selvaraj et al.
2014). Therefore these compounds may be involved to some
extent in the antinociceptive effects observed in our study. On
the other hand, rutin isolated from the Schinus molle L. ex-
hibits antidepressant-like effect in the tail suspension test with-
out the effect on forced swim test and locomotor activity after
oral administration (Machado et al. 2008). Furthermore, as
shown by Dimpfel (2009), rutin and quercitin exhibit anti-
depressant activity in rats through inhibition of monoamine
oxidase and elevation of serotonin and noradrenalin availabil-
ity. Based on these reports we suggest that rutin occurring in
the aqueous extract of C. zacatechichi should not be consid-
ered as responsible for its depressant-like effect in vivo.
On the other hand, Martínez-Vázquez et al. (2012) have
recently demonstrated that the aqueous extract of
Dracocephalum moldavica L. (Lamiaceae) also produce a
depressant-like effect in forced swim test in mice. The chem-
ical analysis of that extract revealed the presence of acacetin
and its derivatives in high concentrations, which may be re-
sponsible for observed depressant activity (Martínez-Vázquez
et al. 2012). Our analysis also showed the presence of acacetin
in the aqueous extract of C. zacatechichi thus the responsibil-
ity of this compound for the increase of immobility time in the
forced swim test cannot be excluded.
The last group of compounds detected by our LC-MS anal-
ysis are germacranolides, including calealactone C and calein
A. There are only a few papers characterizing potential biolog-
ical activity of germacranolides, all of which show their anti-
microbial and anti-oxidative activity, but none of them assessed
their activity in vivo (Umemura et al. 2008; Wu et al. 2011).
This opens up a novel field for further investigations character-
izing the in vivo effects of isolated germacranolides.
Conclusion
The aqueous extract of C. zacatechichi does not affect basic
neurological functions or anxiety and exploratory behavior in
mice after oral administration. On the other hand, it has been
demonstrated in the literature that this plant preparations ex-
hibit potent beneficial activities both in vitro and in vivo.
Further chemical analyses of C. zacatechichi are thus urgently
needed in order to find its all active constituents and identify
which of them are responsible for the effects observed in vivo.
Such findings may open up novel opportunities in design and
synthesis of novel drugs.
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Table 1 Chemical characterization of the C. zacatechichi DCM extract
No. a[M + H]+
(m/z)
Empirical formula Name Reference
1 a355.102 C16H18O9 Chlorogenic acid Zatorski et al. 2015
2 a611.161 C27H30O16 Rutin Reference standard
3 a595.166 C27H30O15 Rutin without hydroxyl group Reference standard
4 a285.076 C16H12O5 Acacetin Liu et al. 2012
5 a407.170 C21H26O8 Calealactone C Wu et al. 2011
6 a421.185 C22H28O8 Calein A Wu et al. 2011
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